Ataman Lauren M, Rodrigues Jhenifer K, Marinho Ricardo M, Caetano João P J, Chehin Maurício B, Alves da Motta Eduardo L, Serafini Paulo, Suzuki Nao, Furui Tatsuro, Takae Seido, Sugishita Yodo, Morishige Ken-Ichiro, Almeida-Santos Teresa, Melo Cláudia, Buzaglo Karen, Irwin Kate, Wallace W Hamish, Anderson Richard A, Mitchell Roderick T, Telfer Evelyn E, Adiga Satish K, Anazodo Antoinette, Stern Catharyn, Sullivan Elizabeth, Jayasinghe Yasmin, Orme Lisa, Cohn Richard, McLachlan Rob, Deans Rebecca, Agresta Franca, Gerstl Brigitte, Ledger William L, Robker Rebecca L, de Meneses E Silva João M, Silva Lígia H F Melo E, Lunardi Franciele O, Lee Jung R, Suh Chang S, De Vos Michael, Van Moer Ellen, Stoop Dominic, Vloeberghs Veerle, Smitz Johan, Tournaye Herman, Wildt Ludwig, Winkler-Crepaz Katharina, Andersen Claus Y, Smith Brigid M, Smith Kristin, Woodruff Teresa K
Lauren M. Ataman, Brigid M. Smith, Kristin Smith, and Teresa K. Woodruff, Feinberg School of Medicine, Northwestern University, Chicago, IL; Jhenifer K. Rodrigues, Ricardo M. Marinho, João P.J. Caetano, Maurício B. Chehin, Eduardo L. Alves da Motta, Paulo Serafini, Brazilian Oncofertility Consortium; Jhenifer K. Rodrigues, Ricardo M. Marinho, and João P.J. Caetano, Pró-Criar Medicina Reprodutiva; Ricardo M. Marinho and João P.J. Caetano, Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte; Maurício B. Chehin, Eduardo L. Alves da Motta, and Paulo Serafini, Huntington Reproductive Medicine and Federal University of São Paulo, São Paulo; João M. de Meneses e Silva, Ceara Blood Center, Centro de Hematologia e Hemoterapia do Ceará, and Assis Chateaubriand Maternity School, Federal University of Ceara; Lígia H.F. Melo e Silva, Federal University of Ceara and Femini Imagem and Ultravida Clinic; Franciele O. Lunardi, State University of Ceara, Fortaleza, Brazil; Nao Suzuki, Seido Takae, and Yodo Sugishita, St Marianna University School of Medicine, Knagawa; Tatsuro Furui and Ken-Ichiro Morishige, Gifu University Graduate School of Medicine, Gifu, Japan; Teresa Almeida-Santos, University Hospital of Coimbra; Teresa Almeida-Santos and Cláudia Melo, University of Coimbra, Coimbra, Portugal; Karen Buzaglo, Clinique Ovo, Montreal, Quebec; Kate Irwin, Cancer Knowledge Network, Milton, Ontario, Canada; W. Hamish Wallace and Roderick T. Mitchell, Edinburgh Royal Hospital for Sick Children; Richard A. Anderson and Roderick T. Mitchell, Queen's Medical Research Institute, University of Edinburgh; Evelyn E. Telfer, Centres for Fertility Preservation and Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom; Satish K. Adiga, Kasturba Medical College, Manipal University, Manipal, India; Antoinette Anazodo and Brigitte Gerstl, Sydney Children's and Prince of Wales Hospital, Future Fertility, Randwick; Elizabeth Sullivan, University of Technology; Richard Cohn, Kids Cancer Centre, Sydney Children's Hospital; Richard Cohn, Rebecca Deans, and William L. Ledger, School of Women's and Children's Health, University of New South Wales, Royal Hospital for Women, Sydney, New South Wales; Catharyn Stern and Franca Agresta, Royal Women's Hospital, University of Melbourne, Melbourne; Yasmin Jayasinghe and Lisa Orme, Children's Cancer Centre, Royal Children's Hospital, Parkville; Rob McLachlan, Monash Institute of Medical Research, Prince Henry's Institute, Clayton, Victoria; Rebecca L. Robker, Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia; Jung R. Lee and Chang S. Suh, Seoul National University Bundang Hospital, Seongnam, and Seoul National University College of Medicine, Seoul, Korea; Michael De Vos, Ellen Van Moer, Dominic Stoop, Veerle Vloeberghs, and Herman Tournaye, Centre for Reproductive Medicine, Universitair Ziekenhuis (UZ) Brussel; Johan Smitz, Laboratory of Clinical Chemistry and Radioimmunology, UZ Brussel, Brussels, Belgium; Ludwig Wildt and Katharina Winkler-Crepaz, Innsbruck Medical University, Innsbruck, Austria; and Claus Y. Andersen, Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Copenhagen, Denmark.
J Glob Oncol. 2016 Apr;2(2):83-96. doi: 10.1200/JGO.2015.000307. Epub 2015 Dec 23.
Fertility preservation in the cancer setting, known as oncofertility, is a field that requires cross-disciplinary interaction between physicians, basic scientists, clinical researchers, ethicists, lawyers, educators, and religious leaders. Funded by the National Institutes of Health, the Oncofertility Consortium (OC) was formed to be a scientifically grounded, transparent, and altruistic resource, both intellectual and monetary, for building this new field of practice capable of addressing the unique needs of young patients with cancer. The OC has expanded its attention to include other nonmalignant conditions that can threaten fertility, and the work of the OC now extends around the globe, involving partners who together have created a community of shared effort, resources, and practices. The OC creates materials that are translated, disseminated, and amended by all participants in the field, and local programs of excellence have developed worldwide to accelerate the pace and improve the quality of oncofertility research and practice. Here we review the global oncofertility programs and the capacity building activities that strengthen these research and clinical programs, ultimately improving patient care.
癌症背景下的生育力保存,即肿瘤生育学,是一个需要医生、基础科学家、临床研究人员、伦理学家、律师、教育工作者和宗教领袖之间进行跨学科互动的领域。由美国国立卫生研究院资助成立的肿瘤生育联盟(OC),旨在成为一个具有科学依据、透明且无私的资源平台,在知识和资金方面为构建这一能够满足年轻癌症患者独特需求的新实践领域提供支持。OC已将关注范围扩大到包括其他可能威胁生育力的非恶性疾病,其工作目前已扩展至全球,涉及众多合作伙伴,他们共同营造了一个共享努力、资源和实践的社区。OC创建的材料由该领域的所有参与者进行翻译、传播和修订,全球各地也已发展出卓越的地方项目,以加快肿瘤生育学研究与实践的步伐并提高其质量。在此,我们回顾全球肿瘤生育项目以及加强这些研究和临床项目的能力建设活动,最终改善患者护理。